02 2016 – Coming soon

Biovica has, by mutual agreement, ended the reference laboratory agreement with Tempus AI, announced in May 2025.

High levels of influenza-specific IgA antibodies in the nasal mucosa are linked to a reduced risk of infection, according to a new study from Danderyd Hospital and SciLifeLab.

The new hub marks an investment in software development and clinical expertise and brings together these capabilities to accelerate the path to one intelligent digital ecosystem across the full perioperative workflow.

Electronic noses open up possibilities for developing non-invasive approaches for early disease detection.

VibroSense Dynamics has initiated legal proceedings to address a breach of the exclusive agreement signed with VibroSense's Chinese distributor Genertec Universal Medical Group Co, a subsidiary of General Technology Holding Co.

Asker Healthcare Group has acquired 100% of the shares in Murray Surgical Limited, a distributor of specialist surgical and medical products to the healthcare sector in Ireland.

The Knut and Alice Wallenberg Foundation has awarded Proof-of-Concept grants to ten life science innovation projects in collaboration with SciLifeLab, alongside seven projects in AI, quantum technologies and ICT, strengthening the route from frontier academic research to commercial and societal impact across Sweden.